Enveda
PrivateLast Round
Series D
9/4/2025
Est. Valuation
$1B
Total Funding Raised
$659.9M
Momentum Score
25 /100
Company Overview
Enveda Biosciences is a biotechnology company that offers a drug discovery platform leveraging machine learning, metabolomics, and robotics to analyze natural samples for chemical structure and biological activity, streamlining the development of new antibiotics and hypotensives for the healthcare industry.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enveda Comps
Public and private peers based on sector, stage, and business model.
Enveda Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | 9/4/2025 | ||||
| Series C | 2/26/2025 | ||||
| Series C | 11/21/2024 | ||||
| Series B Extension | 6/14/2024 | ||||
| Series B Extension | 4/20/2023 | ||||
Series B | 12/21/2022 |
Key People
Founding team and executive leadership
Enveda Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lingotto | Series D |
| Global Village | Seed, Series A |
| Wireframe Ventures | Series B, Series A, Seed, Series B Extension |
| Lingotto Innovation | Series C |
| Dimension | Series D |
| JAZZ Venture Partners | Series B, Series B Extension |
| Lifeforce Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 8, 2026
ENV-294 is one of the lead assets in clinical trials.
- Jan 1, 2026
Named one of Fast Company's Most Innovative Companies in 2026.
Enveda Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Enveda's valuation, stock price, and market status.
